Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -84.30% this year. Over the last six months, there has been a stronger performance of -81.10%. The price of XFOR fallen by 91.28% during the last 30 days period. For the last 5-days stocks have improved 91.28%.
X4 Pharmaceuticals Inc (XFOR) has a current stock price of $2.85. During the previous trading session, the stock witnessed a notable rise, reaching a high of $120.0 after opening at $2.85. The stock’s low for the day was $3.5, and it eventually closed at $3.14.
X4 Pharmaceuticals Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $26.83 on 12/31/24, with the lowest value being $1.35 on 08/11/25.
52-week price history of XFOR Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. X4 Pharmaceuticals Inc’s current trading price is -89.38% away from its 52-week high, while its distance from the 52-week low is 111.11%. The stock’s price range over this timeframe has been between $1.35 and $26.83. The shares of the Healthcare sector company recorded a trading volume of approximately 1.82 million for the day, which was comparatively lower than the average daily volume of 3.72 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
X4 Pharmaceuticals Inc (XFOR) has experienced a quarterly decline of -5.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 32.51M and boasts a workforce of 143 employees.
Expert Opinions: Analysts’ Ratings for X4 Pharmaceuticals Inc
As of right now, 3 analysts are rating X4 Pharmaceuticals Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.51, with a change in price of -6.00. Similarly, X4 Pharmaceuticals Inc recorded 2,406,959 in trading volume during the last 100 days, posting a change of -67.80%.
XFOR’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for XFOR stands at 19.65. Similarly, the long-term debt-to-equity ratio is also 19.31.
XFOR Stock Stochastic Average
The raw stochastic average for X4 Pharmaceuticals Inc over the last 50 days is presently at 47.92%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 71.43%. Further, the company’s Stochastic %K and %D values for the last 20 days were 77.30% and 74.01%, respectively.
